Synovics Pharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jyotindra Gange
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 15.3yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 15.4yrs |
Recent management updates
No updates
Recent updates
No updates
CEO
Jyotindra Gange (74 yo)
15.3yrs
Tenure
Mr. Jyotindra R. Gange has been an Interim Principal Executive Officer at Synovics Pharmaceuticals, Inc. since July 3, 2008. Mr. Gange serves as Chief Financial Officer of Maneesh Pharmaceuticals, Ltd. Pre...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim Principal Executive Officer & Director | 15.4yrs | no data | no data | |
| Chairman of InCon Technologies Inc.& Incon International Ltd. & CEO of InCon Technologies Inc | no data | no data | no data | |
| Director | 15.5yrs | no data | no data | |
| Director | 15.4yrs | US$491.11k | no data | |
| Director | 15.4yrs | no data | no data |
15.4yrs
Average Tenure
73yo
Average Age
Experienced Board: SYVC's board of directors are seasoned and experienced ( 15.4 years average tenure).